How it began

Who we are

Alken was established in 2005 as an independently owned firm, starting as an European Equity specialist boutique. 

The core principle behind our investment philosophy has been to maximise the long-term shareholders’ return consistently. 

In 2017, Alken decided to start a quantitative business with the launch of Cabestan Quant Research. After four years of in-depth research, the first strategy was launched in March 2021. 

In 2018, Alken expanded into fixed-income and announced the appointment of a seasoned team with a broad expertise in the asset class. Two strategies were launched in the same year.

​

Our objective was to build a diversified product portfolio offering which aims at addressing different investors' risk profiles.

Our DNA

What we believe in

Pursuing a high conviction, concentrated and pragmatic investment approach. 

Aiming at having a robust, flexible and replicable investment process focused on identifying critical drivers of long-term performance.

Having an extensive expertise in their area of responsibility with each team being fully independent

Making investment decisions according to the risk profile of the team’s strategies.

Considering environmental, social and governance factors as an integral part of our investment process.

European Equites

Genuine active management

Investment decisions driven by facts

Active engagement to assess the business from an entrepreneurial approach

ESG factors fully integrated 

Global Fixed Income

Genuine bottom-up investment approach with an ESG focus

​

Expertise across a range of fixed

income asset types

​

Target optimal balance between risk

and return

​

Strong and proven track record

Alternatives

Pure quantitative approach

​

Strong culture of rigorous research

Seeking to achieve attractive risk adjusted return profile

Low correlation to traditional asset classes